Aberrant brain entropy in posttraumatic stress disorder comorbid with major depressive disorder during the coronavirus disease 2019 pandemic

Shishun Fu, Sipei Liang, Chulan Lin, Yunfan Wu, Shuangcong Xie, Meng Li, Qiang Lei, Jianneng Li, Kanghui Yu, Yi Yin, Kelei Hua, Wuming Li, Caojun Wu, Xiaofen Ma, Guihua JiangFrontiers in Psychiatry 2023 · DOI

Abstract

The results showed that the R_MFOG is a potential marker for showing the symptom severity of PTSD-MDD comorbidity. Consequently, PTSD-MDD may have reduced BEN in frontal and basal ganglia regions which are related to emotional dysregulation and cognitive deficits.

Introduction

Posttraumatic Stress Disorder (PTSD) and Major Depressive Disorder (MDD) frequently co-occur, particularly in the wake of large-scale societal stressors like the COVID-19 pandemic. While traditional neuroimaging has historically focused on static snapshots of brain activity, the human brain is a dynamic system characterized by constant fluctuations. This study addresses the need for a more nuanced understanding of neural flexibility using brain entropy (BEN).

In this context, entropy measures the unpredictability or complexity of brain signal fluctuations. A healthy brain typically maintains high entropy to process information flexibly across various states. Conversely, lower entropy suggests a more rigid, less adaptive neural system. This research sought to identify whether specific aberrant entropy patterns could explain the emotional and cognitive deficits observed in patients suffering from comorbid PTSD-MDD following pandemic-related trauma.

Methodology

The researchers utilized resting-state functional magnetic resonance imaging (rs-fMRI) to observe spontaneous brain activity in 33 drug-naive patients with PTSD-MDD and 36 matched "traumatized controls" (TCs). The TCs were individuals who experienced significant stressors, such as home quarantine, but did not develop psychiatric symptoms.

Technical Approach

  • Sample Entropy (SampEn): The team employed the SampEn algorithm to calculate BEN maps from fMRI time-series data. SampEn is favored for biological data due to its stability in shorter datasets and lower sensitivity to noise.
  • Clinical Assessment: Physical brain changes were correlated with subjective symptom severity using the Clinician-Administered PTSD Scale (CAPS) and the Hamilton Depression Scale-24 items (HAMD-24).
  • Statistical Analysis: A two-sample t-test with False Discovery Rate (FDR) correction was applied to ensure the validity of the observed differences between the patient and control groups.

Neuroanatomical Findings

The study identified three specific regions with significantly reduced entropy in PTSD-MDD patients compared to controls: the right middle frontal orbital gyrus (R_MFOG), the left putamen, and the right inferior frontal gyrus (R_IFOG). These areas are integral to emotion regulation and cognitive processing.

Brain regions showing reduced entropy (BEN) in PTSD-MDD patients, highlighting the R_MFOG and basal ganglia.

Reduced entropy in the putamen, a key component of the basal ganglia, suggests that the irregularity of signals within reward and motor circuits is compromised. This neurobiological rigidity may explain clinical symptoms such as anhedonia (the inability to feel pleasure) and the cognitive "slowness" frequently reported by comorbid patients.

Clinical Correlations and Results

A primary finding of the study is the role of the R_MFOG as a sensitive biomarker. While the patient group generally exhibited lower entropy in this region than healthy controls, a significant correlation was found within the patient group: individuals with relatively higher entropy in the R_MFOG reported more severe symptoms.

Scatter plots illustrating the positive correlation between R_MFOG brain entropy values and clinical symptom scores (CAPS and HAMD-24).

Specifically, higher BEN values in the R_MFOG were positively correlated with higher HAMD-24 scores ($r = 0.479, p = 0.002$) and CAPS scores ($r = 0.366, p = 0.036$). This suggests that the complexity of neural firing in the prefrontal cortex is a key differentiator in how individuals process traumatic stress and depressive symptoms during a crisis.

Limitations and Future Directions

While these findings provide a promising biomarker for PTSD-MDD, the authors acknowledge several limitations:

  • Diagnostic Specificity: The study lacked "PTSD-only" or "MDD-only" comparison groups, making it difficult to isolate whether these entropy changes are unique to the comorbidity or driven by one disorder.
  • Sample Size: The cohort of 69 participants limits statistical power; larger, multi-center studies are required for validation.
  • Biological Basis: The exact neurophysiological meaning of entropy (e.g., its relationship to neurotransmitter levels or synaptic density) remains to be fully elucidated.
  • Temporal Dynamics: As a cross-sectional study, it remains unclear if BEN levels normalize following successful clinical intervention. Future longitudinal research is necessary to track these biomarkers over time.

Summary updated

Abstract

The results showed that the R_MFOG is a potential marker for showing the symptom severity of PTSD-MDD comorbidity. Consequently, PTSD-MDD may have reduced BEN in frontal and basal ganglia regions which are related to emotional dysregulation and cognitive deficits.
BibTeX
@inproceedings{fu2023aberrant,
  author = {Shishun Fu and Sipei Liang and Chulan Lin and Yunfan Wu and Shuangcong Xie and Meng Li and Qiang Lei and Jianneng Li and Kanghui Yu and Yi Yin and Kelei Hua and Wuming Li and Caojun Wu and Xiaofen Ma and Guihua Jiang},
  title = {{Aberrant brain entropy in posttraumatic stress disorder comorbid with major depressive disorder during the coronavirus disease 2019 pandemic}},
  booktitle = {Frontiers in Psychiatry},
  year = {2023},
  doi = {10.3389/fpsyt.2023.1143780},
}
Figure